Randomized, Double-blind, Placebo-Controlled Pilot Study of MDMA-assisted Therapy for PTSD

NCT01689740 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Posttraumatic Stress Disorder (PTSD)

Interventions

DRUG: Active Placebo Dose MDMA-assisted therapy (25 mg)
DRUG: Full Dose MDMA-assisted therapy (125 mg)
DRUG: Open-Label Full Dose MDMA-assisted therapy (125 mg)
BEHAVIORAL: Psychotherapy

Sponsor

Resilient Pharmaceuticals